Alliance Pharma

www.alliancepharma.co.uk Profile page

Follow

Follow

Only registred members can create thier own customized alerts.

Help
Watchlist/Portfolio

Add to watchlist:
Only registered members can add into watchlist !

Register here !

Alliance Pharma plc is a United Kingdom-based pharmaceutical company. The Company is engaged in the development, marketing and distribution of pharmaceutical products. Its brands include Nu-Seals, Forceval, Hydromol, Deltacortril, Symmetrel, Syntocinon, Naseptin, Syntometrine, Synacthen and Slow-K.

Website:: http://www.alliancepharma.co.uk/
Phone:: +44 (0)1249 466 966
Address:: Avonbridge House, Bath Road, Chipperham, Wiltshire SN15 2BB.

Super Sector:: Pharmaceuticals & Biotechnology
Sector:: Pharmaceuticals & Biotechnology
Industry:: Pharmaceuticals
EPIC / Symbols:: LON:APH, LON:APHA

Print
Email

Email to a friend:

To: From: Name: Description:
Verification code
Enter the code from aboveRequired
RSS

Alliance Pharma Related Media

Page 1 of 1

30/03/2012

Stocktube video - Alliance Pharma CEO looks forward to continued good growth prospects

John Dawson, CEO of Alliance Pharma (LON:APH) tells Proactiveinvestors that the future is looking good. With sales rising at 19% compound pa over the last five years, rising profitability, falling debt and a "progressive dividend strategy", everything is there. John says that he and his team will just continue proving the business model, making more acquisitions and then let the market catch up.
29/03/2012

Alliance Pharma One2One Investor Forum - 29th March 2012 (PDF)

Alliance Pharma One2One Investor Forum - 29th March 2012
24/06/2011

Stocktube video - Alliance Pharma CEO John Dawson says fundamentals remain intact

John Dawson, CEO of Alliance Pharma (LON:APH), tells Proactive Investors that despite the drop in shares the company remains very much focussed on its original strategy of expansion and its progressive dividend policy. John talks about the acquisition opportunities in the areas where it operates.
23/06/2011

Alliance Pharma One2One Investor Forum - 23rd June 2011 (PDF)

Alliance Pharma One2One Investor Forum - 23rd June 2011
16/07/2010

Stocktube video - Alliance Pharma confirm they are on track with promising growth prospects

John Dawson, CEO Alliance Pharma, talks to Proactive Investors about the profit outlook and how the company will deal with impending competition.
20/04/2010

Alliance Pharma One2One Investor Presentation 20 April 10 (PDF)

Alliance Pharma updates investors at the One2One Investor Forum on 20 April 2010
22/07/2009

Alliance Pharma One2One Investor Presentation 22 July 2009 (PDF)

John Dawson, CEO of Alliance Pharma, updates investors at the Proactive Investors One2One Forum on 22 July 2009.